surmount-1 tirzepatide weight loss nondiabetic FDA Grants a New Indication for Obesity Management Tirzepatide cuts diabetes risk by

If the tool isnt able to find information about your Ozempic coverage, you can ask NovoCare to contact Aetna on your behalf

Semaglutide (5mg-20mg), Long-Acting GLP-1 Receptor Agonist An Acylated Analog of Native GLP-1(7-37) Introduction An Acylated Analog of Native GLP-1(7-37) Semaglutide is a 31-residue synthetic GLP-1 analog engineered through structural modification of native human GLP-1(7-37)

1 Upon analysis, results suggested the placebo-adjusted systolic blood pressure changes from baseline were 7.4 (95% CI, 10.0 to 4.7) mmHg, 10.6 (95% CI, 13.2 to 8.0) mmHg , and 8.0 (95% CI, 10.6 to 5.4) mmHg for tirzepatide 5, 10, and 15 mg, respectively

TRICARE beneficiaries who may qualify include: Active duty service members Family members of active duty personnel Retirees and eligible dependents Eligibility depends on enrollment in TRICARE plans and meeting medical necessity criteria